Inozyme Pharma
Latest round
- Series A
Last raised
- Jun 2020
Total raised
- $83M
Investors
- 9
About Inozyme Pharma
Founded in 2016, Inozyme Pharma Inc is engaged in developing therapies for rare diseases. The company is headquartered in Boston, US.00 mn through an Add-on Trade Sale.50 mn, with BioMarin Pharmaceutical Inc.Inozyme Pharma specializes in investigational therapies targeting rare diseases related to the PPi-Adenosine Pathway, crucial for healthy bone and blood vessel maintenance. Its product pipeline includes potential treatments for ENPP1 Deficiency, ABCC6 Deficiency, and calciphylaxis, all lacking approved therapies.Inozyme Pharma generates revenue primarily through clinical trial activities and the development of investigational therapies, supported by partnerships, grants, and anticipated future product sales. The company engages in B2B transactions with healthcare providers and research institutions, enrolling participants in clinical trials for its novel therapies. The company is focused on expanding its clinical trials for existing products and exploring new markets in North America and Europe.
Who invested in Inozyme Pharma
9 investors across 2 rounds
See all investors in Inozyme Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inozyme Pharma
Who invested in Inozyme Pharma?
Inozyme Pharma has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inozyme Pharma raised?
Inozyme Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Inozyme Pharma last raise money?
Inozyme Pharma's most recent round on record is a Series A, in Jun 2020.
What does Inozyme Pharma do?
Founded in 2016, Inozyme Pharma Inc is engaged in developing therapies for rare diseases.
Where is Inozyme Pharma headquartered?
Inozyme Pharma is headquartered in Boston, US.
Which VCs invest in companies like Inozyme Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Inozyme Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Inozyme Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.